Summary
The publisher's Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2020“. Transcatheter Mitral Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium) is placed in a long narrow tube known as a catheter.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to -
The publisher's Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2020“. Transcatheter Mitral Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium) is placed in a long narrow tube known as a catheter.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products under Development by Companies
5 Transcatheter Mitral Valve Implantation (TMVI) Companies and Product Overview
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4C Medical Technologies Inc
- Anchorvalve
- Annulon
- Cardiovalve Ltd
- Cephea Valve Technologies, Inc.
- Colibri Heart Valve LLC
- Direct Flow Medical Inc (Inactive)
- Dura LLC
- Edwards Lifesciences Corp
- Emory University
- Foldax Inc
- HighLife SAS
- LivaNova PLC
- Medtronic Plc
- Micro Interventional Devices, Inc.
- MitrAssist Ltd.
- MValve Technologies Ltd.
- NaviGate Cardiac Structures, Inc.
- Neovasc Inc
- NewMed Medical Co Ltd
- P+F Products + Features GmbH
- Polares Medical SA
- Sino Medical Sciences Technology Inc
- Trinity College Dublin
- University College London
- Venus MedTech
